Michele Volansky
Physician Assistant · Atlanta, GANPI 1003944778
Payments from drug & device makers
Across 421 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$2K
- Amgen$1K
- Sanofi$803
- Johnson & Johnson$749
- UCB, Inc.$675
- plus $2K from 18 others
What the payments were for
- Speaking & faculty fees$1,50016%
- Food & beverage$7,64181%
- Education$2353%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 148 | $1,959 |
| AstraZeneca | 14 | $1,721 |
| Amgen(2 entities) | 93 | $1,492 |
| Sanofi | 21 | $803 |
| Johnson & Johnson | 23 | $749 |
| UCB, Inc. | 36 | $675 |
| Novartis | 30 | $505 |
| GSK | 12 | $261 |
| ANI Pharmaceuticals, Inc. | 1 | $220 |
| Radius Health, Inc. | 6 | $150 |
| Lilly USA, LLC | 6 | $138 |
| Genentech USA, Inc. | 6 | $124 |
| Sobi, Inc | 4 | $93 |
| Organon | 4 | $93 |
| Pfizer | 5 | $85 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| Sandoz | 2 | $52 |
| E.r. Squibb & Sons, L.L.C. | 2 | $45 |
| Boehringer Ingelheim | 2 | $43 |
| Aurinia Pharma U.S., Inc. | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Celltrion USA Inc. | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $17 |
| IBSA Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPHNELO$1,500
- PURIFIED CORTROPHIN GEL$220
- Tremfya$116
- SIMPONI ARIA$116
How this compares
$9,376 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf)Adalimumab | 17 | $138,039 |
| Enbrel SureclickEtanercept | 17 | $135,035 |
| RinvoqUpadacitinib | 15 | $106,834 |
| XeljanzTofacitinib Citrate | 14 | $76,768 |
| Hydroxychloroquine Sulfate | 61 | $2,860 |
| MethotrexateMethotrexate Sodium | 95 | $1,822 |
| Leflunomide | 17 | $733 |
| Allopurinol | 32 | $331 |
| Methylprednisolone | 53 | $261 |
| Prednisone | 58 | $251 |
| Gabapentin | 24 | $233 |
| Methocarbamol | 11 | $169 |
| Celecoxib | 15 | $98 |
| Methotrexate SodiumMethotrexate Sodium/Pf | 11 | $77 |
| Cyclobenzaprine Hcl | 19 | $72 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieHumira(Cf), Rinvoq | $1,959 | $244,87332 claims |
| PfizerXeljanz | $85 | $76,76814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Atlanta
- Jennifer CobbsAtlanta$1M
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Jaime AckermanAtlanta$84K
- Andrew GoodnerAtlanta$56K
- Tiffany LangemanAtlanta$53K
- Amy SimoneAtlanta$51K
- Rachel NeelyAtlanta$44K
- Jennifer YoungAtlanta$32K
- Kia CampbellAtlanta$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.